Surgical oncology. Alternatives to surgery after failure of instillation therapy.
Management of high-risk non-muscle-invasive bladder cancer represents a difficult challenge in clinical practice. the dilemma is to decide between an organ-sparing approach or radical cystectomy with the risk of undertreatment or overtreatment for this group of patients. This issue is especially important for patients who have failed previous intravesical therapy.